FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal2020; 52(5); 643-650; doi: 10.1111/evj.13312

Study design synopsis: Designing and performing pharmacokinetic studies for systemically administered drugs in horses.

Abstract: The goal of this editorial is to discuss best practice design, execution and reporting of a pharmacokinetic (PK) study in horses. Our target readers are clinicians who plan to perform this type of research, in a field, clinic or research setting but we also hope that this article might help readers of such work to appraise the articles and understand the quality of the studies. Our emphasis will be on appropriate study design and analytical method, drug and drug formulation choice and route of administration, animal choice, sample collection, storage and shipping, and reporting, rather than the PK data analysis itself.
© 2020 EVJ Ltd.
Get Full Text
Publication Date: 2020-08-05 PubMed ID: 32748990DOI: 10.1111/evj.13312Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Editorial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article predominantly focuses on optimal practices in conducting and communicating pharmacokinetic (PK) studies on horses, concerning systemic drug administration. It delivers valuable insights for veterinarians, scholars, and other practitioners engaged in horse-related medical research.

Study Design and Analytical Method

  • The research outlines the importance of a well-crafted study design in collecting reliable and relevant data in pharmacokinetic studies on horses.
  • Moreover, the authors emphasize on using a suitable analytical method that aligns with the study’s objectives and nature of the drug tested.

Choice of Drug and Its Administration

  • The manuscript underlines the necessity of thoughtful drug and drug formulation selection. The choice should consider factors such as the purpose and potential side effects of the medicine.
  • The route of drug administration also plays a crucial role in generating viable data and subsequently impacts the study outcomes.

Participant Selection

  • This research emphasizes on the appropriateness of animal selection. The authors caution practitioners to carefully choose horses that are suitable for pharmacokinetic studies, depending on the specifics of individual studies.

Sample Collection, Storage, and Shipping

  • The paper outlines the importance of well-planned sample collection procedures, which must ensure that samples are preserved in a state suitable for animated analysis.
  • It also indicates the necessity of correct sample shipping and storage practices that assure sample integrity until the time of analysis.

Report Writing

  • Finally, the authors stress the importance of accurate and comprehensive reporting of the study process and results. This transparency enables others to evaluate the research’s quality, methods, and conclusions.

Notably, the researchers do not concentrate on the analysis of pharmacokinetic data itself, but instead, they steer their attention towards foundational elements that add up to the overall success of a pharmacokinetic study.

Cite This Article

APA
Bermingham E, Davis JL, Whittem T. (2020). Study design synopsis: Designing and performing pharmacokinetic studies for systemically administered drugs in horses. Equine Vet J, 52(5), 643-650. https://doi.org/10.1111/evj.13312

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 52
Issue: 5
Pages: 643-650

Researcher Affiliations

Bermingham, Eden
  • Animal Clinical Investigation LLC, Chevy Chase, MD, USA.
Davis, Jennifer L
  • Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USA.
Whittem, Ted
  • University of Melbourne, Melbourne Veterinary School, Werribee, VIC, Australia.

MeSH Terms

  • Animals
  • Horses
  • Pharmaceutical Preparations
  • Research Design

References

This article includes 22 references
  1. . FDA guidance for industry #85 VICH GL9 good clinical practice. .
  2. . VICH GL9 good clinical practices. .
  3. . Code of federal regulations part 58 good laboratory practice. .
  4. . FDA guidance for industry # 224 VICH GL52 bioequivalence: blood level bioequivalence study and supplement. .
  5. . VICH GL52 bioequivalence: blood level bioequivalence study. .
  6. . FDA guidance for industry: bioanalytical method validation. .
  7. Woodward A, Whittem T. The lower limit of quantification in pharmacokinetic analyses. J Vet Pharmcol Ther 2019;42:585-7.
  8. Skolnik JM, Zhang AY, Barrett JS, Adamson PC. Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer. Ther Drug Monit 2010;32(6):741-8.
  9. Korsrud GO, Boison JO, Papich MG. Depletion of intramuscularly and subcutaneously injected procaine penicillin G from tissues and plasma of yearling beef steers. Can J Vet Res 1993;57(4):223-30.
  10. Toutain PL, Lassourd V, Costes G. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J Vet Pharmacol Ther 1995;18:226-35.
  11. Messenger KM, Davis JL, LaFevers DH, Barlow BM, Posner LP. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site. Vet Anaesth Analg 2011;38(4):374-84.
  12. Rivero JL, Ruz A, Martí-Korff S, Estepa JC, Aguilera-Tejero E, Werkman J. Effects of intensity and duration of exercise on muscular responses to training of thoroughbred racehorses. J Appl Physiol 2007;102(5):1871-82.
  13. Corado CR, McKemie DS, Young A, Knych HK. Evidence for polymorphism in the cytochrome P450 2D50 gene in horses. J Vet Pharmacol Ther 2016;39(3):245-54.
  14. Powers J. Statistical analysis of pharmacokinetic data. J Vet Pharmacol Ther 1990;13:113-20.
  15. Whittem T. The population distribution of some pharmacokinetic parameters is not normal. A prediction based on computer modelling. NZ Med J 1993;106:37.
  16. Dasgupta A, Dean R, Saldana S, Kinnaman G, McLawhon RW. Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Volume- and time-dependent reduction in total and free drug concentrations. Am J Clin Pathol 1994;101(4):456-61.
  17. Veng-Pedersen P. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part 1). Clin Pharmacokinet 1989;17(5):345-66.
  18. . CLSI VET 02 development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents. 3rd ed. .
  19. . CLSI VET 01 supplement (VET08) performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 4th ed. .
  20. . CLSI VET09 understanding susceptibility test data as a component of antimicrobial stewardship in veterinary settings. 1st ed. .
  21. . EUCAST. .
  22. . Guideline on how to collect, archive, handle, and analyze pharmacokinetic data for EUCAST. .

Citations

This article has been cited 4 times.
  1. O O, Simon BT, Ebner LS, Lizarraga I, Sun X, Cox SK. The pharmacokinetics and pharmacodynamics of midazolam after intravenous administration to donkeys (Equus africanus asinus). Can J Vet Res 2022 Apr;86(2):125-131.
    pubmed: 35388227
  2. Martinez MN, Papich MG, Fahmy R. Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics. ADMET DMPK 2022;10(1):1-25.
    doi: 10.5599/admet.1140pubmed: 35360673google scholar: lookup
  3. Serrano-Rodríguez JM, Miraz R, Saitua A, Díez de Castro E, Ledesma-Escobar C, Ferreiro-Vera C, Priego-Capote F, Sánchez de Medina V, Sánchez de Medina A. Metabolism, pharmacokinetics, and bioavailability of cannabigerol in horses following intravenous and oral administration with micellar and oil formulations. Front Vet Sci 2025;12:1688214.
    doi: 10.3389/fvets.2025.1688214pubmed: 41234397google scholar: lookup
  4. Di Salvo A, Bazzano M, Rocca GD, Galarini R, Marchegiani A, Paoletti F, Giusepponi D, Mantovani M, Laus F. Pharmacokinetics of a single oral administration of two cannabidiol formulations in fed and fasted horses. Front Vet Sci 2025;12:1515833.
    doi: 10.3389/fvets.2025.1515833pubmed: 40046423google scholar: lookup
Subscribe to our newsletter
Join 100,113 horse owners like you who receive our email updates on horse health and nutrition.